Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Drug Resistance

Free Subscription 24.06.2019 4 Antimicrob Agents Chemother 1 Clin Infect Dis 4 Emerg Infect Dis 2 Int J Antimicrob Agents 1 J Antimicrob Chemother 4 J Infect Chemother 1 JAMA

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Antimicrob Agents Chemother

1. LEE H, Boyle-Vavra S, Ren J, Jarusiewicz J, et al
   Identification of small molecules exhibiting oxacillin synergy through a novel assay for inhibition of vraTSR expression in methicillin resistant Staphylococcus aureus.
   Antimicrob Agents Chemother. 2019 Jun 17. pii: AAC.02593.
   PubMed     Text format     Abstract available
   
   
2. BERKOW EL, Nunnally NS, Bandea A, Kuykendall R, et al
   Detection of TR34/L98H Cyp51A mutation through passive surveillance for azole-resistant Aspergillus fumigatus in the US, 2015-2017.
   Antimicrob Agents Chemother. 2018 Feb 20. pii: AAC.02240.
   PubMed     Text format     Abstract available
   
   
3. PARQUET MDC, Savage KA, Allan DS, Ang MTC, et al
   Antibiotic resistant Acinetobacter baumannii is susceptible to the novel iron-sequestering anti-infective DIBI in vitro and in experimental pneumonia in mice.
   Antimicrob Agents Chemother. 2019 Jun 17. pii: AAC.00855.
   PubMed     Text format     Abstract available
   
   
4. DOLEJSKA M, Literak I
   Wildlife is overlooked in the epidemiology of medically important antimicrobial resistant bacteria.
   Antimicrob Agents Chemother. 2019 Jun 17. pii: AAC.01167.
   PubMed     Text format     Abstract available
   
   

   
   Clin Infect Dis

5. DYMOND A, Davies H, Mealing S, Pollit V, et al
   Genomic surveillance of methicillin-resistant Staphylococcus aureus: a mathematical early modelling study of cost effectiveness.
   Clin Infect Dis. 2019 Jun 18. pii: 5521015. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Emerg Infect Dis

6. MARTENS L, Kuster S, de Vos W, Kersten M, et al
   Macrolide-Resistant Mycoplasma genitalium in Southeastern Region of the Netherlands, 2014-2017.
   Emerg Infect Dis. 2019;25:1297-1303.
   PubMed     Text format     Abstract available
   
   
7. LANGELIER C, Graves M, Kalantar K, Caldera S, et al
   Microbiome and Antimicrobial Resistance Gene Dynamics in International Travelers.
   Emerg Infect Dis. 2019;25:1380-1383.
   PubMed     Text format     Abstract available
   
   
8. RIZZO K, Horwich-Scholefield S, Epson E
   Carbapenem and Cephalosporin Resistance among Enterobacteriaceae in Healthcare-Associated Infections, California, USA(1).
   Emerg Infect Dis. 2019;25:1389-1393.
   PubMed     Text format     Abstract available
   
   
9. WALTERS MS, Grass JE, Bulens SN, Hancock EB, et al
   Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015.
   Emerg Infect Dis. 2019;25:1281-1288.
   PubMed     Text format     Abstract available
   
   

   
   Int J Antimicrob Agents

10. LEE YL, Lu MC, Shao PL, Lu PL, et al
    Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria with an emphasis on carbapenems and colistin: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018.
    Int J Antimicrob Agents. 2019 Jun 13. pii: S0924-8579(19)30162.
    PubMed     Text format     Abstract available
    
    
11. SMOKE S, Raja K, Narayanan N, Brunetti L, et al
    Selective Antibiotic Susceptibility Reporting and Broad-Spectrum Intravenous Antibiotic Use: a Multicenter Ecological Study.
    Int J Antimicrob Agents. 2019 Jun 13. pii: S0924-8579(19)30164.
    PubMed     Text format     Abstract available
    
    

    
    J Antimicrob Chemother

12. PITT R, Sadouki Z, Town K, Fifer H, et al
    Detection of tet(M) in high-level tetracycline-resistant Neisseria gonorrhoeae.
    J Antimicrob Chemother. 2019;74:2115-2116.
    PubMed     Text format    
    
    

    
    J Infect Chemother

13. KATO H, Yamagishi Y, Hagihara M, Yokoyama Y, et al
    Antimicrobial activity of solithromycin and levofloxacin against a murine pneumonia mixed-infection model caused by Streptococcus pneumoniae and anaerobic bacteria.
    J Infect Chemother. 2019;25:311-313.
    PubMed     Text format     Abstract available
    
    
14. HIGA S, Sarassari R, Hamamoto K, Yakabi Y, et al
    Characterization of CTX-M type ESBL-producing Enterobacteriaceae isolated from asymptomatic healthy individuals who live in a community of the Okinawa prefecture, Japan.
    J Infect Chemother. 2019;25:314-317.
    PubMed     Text format     Abstract available
    
    
15. KOBAYASHI I, Kanesaka I, Kanayama Katsuse A, Takahashi H, et al
    Gene expression analysis in the potent bactericidal activity of sitafloxacin against Streptococcus pneumoniae.
    J Infect Chemother. 2019;25:322-324.
    PubMed     Text format     Abstract available
    
    
16. YAMAKAWA H, Kosai K, Akamatsu N, Matsuda J, et al
    Molecular and epidemiological analysis of IMP-1 metallo-beta-lactamase-producing Klebsiella pneumoniae in a tertiary care hospital in Japan.
    J Infect Chemother. 2019;25:240-246.
    PubMed     Text format     Abstract available
    
    

    
    JAMA

17. FRIEDRICH MJ
    UN: All-out Effort Needed to Combat Antimicrobial Resistance.
    JAMA. 2019;321:2273.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: